Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 10 of 101 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Show all pathways known for 6.1.1.4Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.4Acidosis, Lactic 20194621 Human mitochondrial leucyl-tRNA synthetase corrects mitochondrial dysfunctions due to the tRNALeu(UUR) A3243G mutation, associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like symptoms and diabetes. causal interaction
unassigned
2
0
Show all pathways known for 6.1.1.4Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.4Acidosis, Lactic 26537577 LARS2 Variants Associated with Hydrops, Lactic Acidosis, Sideroblastic Anemia, and Multisystem Failure. causal interaction
unassigned
2
0
Show all pathways known for 6.1.1.4Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.4Acidosis, Lactic 28847973 Correction for Li and Guan, "Human Mitochondrial Leucyl-tRNA Synthetase Corrects Mitochondrial Dysfunctions Due to the tRNA(Leu(UUR)) A3243G Mutation, Associated with Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Symptoms and Diabetes". causal interaction
unassigned
1
0
Show all pathways known for 6.1.1.4Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.4Acidosis, Lactic 32442335 The expanding LARS2 phenotypic spectrum: HLASA, Perrault syndrome with leukodystrophy, and mitochondrial myopathy. causal interaction
ongoing research
therapeutic application
unassigned
3
1
1
0
Show all pathways known for 6.1.1.4Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.4Anemia 33300650 Severe course with lethal hepatocellular injury and skeletal muscular dysgenesis in a neonate with infantile liver failure syndrome type 1 caused by novel LARS1 mutations. causal interaction
therapeutic application
unassigned
4
1
0
Show all pathways known for 6.1.1.4Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.4Anemia, Sideroblastic 26537577 LARS2 Variants Associated with Hydrops, Lactic Acidosis, Sideroblastic Anemia, and Multisystem Failure. causal interaction
unassigned
2
0
Show all pathways known for 6.1.1.4Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.4Anemia, Sideroblastic 32442335 The expanding LARS2 phenotypic spectrum: HLASA, Perrault syndrome with leukodystrophy, and mitochondrial myopathy. causal interaction
ongoing research
therapeutic application
unassigned
3
1
1
0
Show all pathways known for 6.1.1.4Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.4Carcinogenesis 18446061 Implication of leucyl-tRNA synthetase 1 (LARS1) over-expression in growth and migration of lung cancer cells detected by siRNA targeted knock-down analysis. causal interaction
diagnostic usage
ongoing research
therapeutic application
4
4
2
2
Show all pathways known for 6.1.1.4Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.4Carcinogenesis 19129950 Inactivation of LARS2, located at the commonly deleted region 3p21.3, by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. causal interaction
diagnostic usage
ongoing research
unassigned
4
4
1
0
Show all pathways known for 6.1.1.4Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.4Carcinoma, Non-Small-Cell Lung 31205503 Therapeutic effects of the novel Leucyl-tRNA synthetase inhibitor BC-LI-0186 in non-small cell lung cancer. ongoing research
therapeutic application
unassigned
3
4
0
Results 1 - 10 of 101 > >>